Curaleaf Holdings, Inc. ( CURLF) - Stock Earnings
CURLF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -48.5 million USD | 320.2 million USD |
| 2025Q4 | -39.5 million USD | 333.1 million USD |
| 2026Q1 | 75.2 million USD | 324.2 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CURLF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -126.1 million USD | 1.3 billion USD |
| 2024 | -123.4 million USD | 1.3 billion USD |
| 2025 | -175.9 million USD | 1.3 billion USD |
| 2026 Est. | — | — |
CURLF
Price: $10.92
52 week price:
Earnings Per Share: -0.36 USD
P/E Ratio: -6.33
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 3.1 billion